Frontiers in Pharmacology (Mar 2023)

Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention

  • Xiaoying Yin,
  • Xiaoying Yin,
  • Xiaoying Yin,
  • Xiaoying Yin,
  • Xinxin Yin,
  • Xinxin Yin,
  • Xinxin Yin,
  • Xinxin Yin,
  • Xin Pan,
  • Xin Pan,
  • Xin Pan,
  • Xin Pan,
  • Jingyu Zhang,
  • Jingyu Zhang,
  • Jingyu Zhang,
  • Jingyu Zhang,
  • Xinhui Fan,
  • Xinhui Fan,
  • Xinhui Fan,
  • Xinhui Fan,
  • Jiaxin Li,
  • Jiaxin Li,
  • Jiaxin Li,
  • Jiaxin Li,
  • Xiaoxuan Zhai,
  • Xiaoxuan Zhai,
  • Xiaoxuan Zhai,
  • Xiaoxuan Zhai,
  • Lijun Jiang,
  • Lijun Jiang,
  • Lijun Jiang,
  • Lijun Jiang,
  • Panpan Hao,
  • Jiali Wang,
  • Jiali Wang,
  • Jiali Wang,
  • Jiali Wang,
  • Yuguo Chen,
  • Yuguo Chen,
  • Yuguo Chen,
  • Yuguo Chen

DOI
https://doi.org/10.3389/fphar.2023.1070973
Journal volume & issue
Vol. 14

Abstract

Read online

Cardiac fibrosis plays an indispensable role in cardiac tissue homeostasis and repair after myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and extracellular matrix collagen deposition are the hallmarks of cardiac fibrosis, which are modulated by multiple signaling pathways and various types of cells in time-dependent manners. Our understanding of the development of cardiac fibrosis after MI has evolved in basic and clinical researches, and the regulation of fibrotic remodeling may facilitate novel diagnostic and therapeutic strategies, and finally improve outcomes. Here, we aim to elaborate pathophysiology, examination and intervention of cardiac fibrosis after MI.

Keywords